Atairos Partners GP, Inc.
BRYN MAWR, PA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$28.5M2026 Q3
Positions2
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
Atairos Partners GP, Inc. reported 2 positions worth $28.5M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: CLVT (60.0%).
2 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | CLVT | $17.1M | 59.97% | 10,232,667 | — | — | +39.5% | |
| ▸ 2 | Advantage Sol… | $11.4M | 40.03% | 439,430 | — | — | — |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Atairos Partners GP, Inc. hold as of Q3 2026?
Atairos Partners GP, Inc. reported 2 positions worth $28.5M in its Q3 2026 13F filing. Largest positions: CLVT (60.0%) and ADVANTAGE SOLUTIONS INC. (40.0%).
What did Atairos Partners GP, Inc. buy in Q3 2026?
Atairos Partners GP, Inc. opened or added to no positions in Q3 2026.
What did Atairos Partners GP, Inc. sell in Q3 2026?
Atairos Partners GP, Inc. reduced or sold out of no positions in Q3 2026.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.